{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:07:52Z","timestamp":1780582072277,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.medcli.2026.107429","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T16:31:48Z","timestamp":1776875508000},"page":"107429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efectividad temprana de anifrolumab en lupus eritematoso sist\u00e9mico: datos de vida real a 3 y 6 meses del registro RALESA"],"prefix":"10.1016","volume":"166","author":[{"given":"Mar\u00eda Dolores","family":"Manj\u00f3n Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"S\u00e1nchez Berna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Garc\u00eda Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"de la Hera Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"P\u00e9rez de Pedro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Gil Morillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Navarrete Navarrete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1653-0087","authenticated-orcid":false,"given":"Jos\u00e9 Luis","family":"Callejas Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda del Mar","family":"Ayala Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Romero G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Le\u00f3n Ru\u00edz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"G\u00f3miz Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Borrachero Garro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ascensi\u00f3n","family":"V\u00edlchez Parras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agust\u00edn","family":"Colodro Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107429_bib0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101814","article-title":"Systemic lupus erythematosus","volume":"36","author":"Tanaka","year":"2022","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0155","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1093\/rheumatology\/keab883","article-title":"Easy-BILAG: A new tool for simplified recording of SLE disease activity using BILAG-2004 index","volume":"61","author":"Carter","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2026.107429_bib0160","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1191\/0961203302lu253oa","article-title":"Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature","volume":"11","author":"Voulgari","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2026.107429_bib0165","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0170","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1177\/0961203318777103","article-title":"Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: A nationwide cohort study in Denmark","volume":"27","author":"Petersen","year":"2018","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2026.107429_bib0175","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6610509","article-title":"Cutaneous manifestations of \u201clupus\u201d: Systemic lupus erythematosus and beyond","volume":"2021","author":"Cooper","year":"2021","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0180","doi-asserted-by":"crossref","first-page":"431","DOI":"10.21037\/atm-20-5048","article-title":"The CLASI, a validated tool for the evaluation of skin disease in lupus erythematosus: A narrative review","volume":"9","author":"Chakka","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.medcli.2026.107429_bib0185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.autrev.2005.01.003","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"4","author":"Werth","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2026.107429_bib0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1001\/jamadermatol.2013.9026","article-title":"Systemic symptoms in the progression of cutaneous to systemic lupus erythematosus","volume":"150","author":"Wieczorek","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0195","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1177\/09612033241311335","article-title":"Systemic lupus erythematosus is a risk factor for having multiple subtypes of cutaneous lupus erythematosus","volume":"34","author":"Lu","year":"2025","journal-title":"Lupus"},{"key":"10.1016\/j.medcli.2026.107429_bib0200","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.3390\/jcm13082419","article-title":"The spectrum of cutaneous manifestations in lupus erythematosus: A comprehensive review","volume":"13","author":"Fija\u0142kowska","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107429_bib0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102615","article-title":"Clinical disease activity and flare in SLE: Current concepts and novel biomarkers","volume":"119","author":"Thanou","year":"2021","journal-title":"J Autoimmun"},{"key":"10.1016\/j.medcli.2026.107429_bib0210","first-page":"504","article-title":"Randomized clinical trials and longitudinal observational studies in systemic lupus erythematosus: consensus on a preliminary core set of outcome domains","volume":"26","author":"Smolen","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0215","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.medcli.2023.12.006","article-title":"Rapid response to anifrolumab in refractory cutaneous lupus erythematosus","volume":"162","author":"Moreno-Torres","year":"2024","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2026.107429_bib0220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.medcli.2024.09.033","article-title":"Impact of belimumab on glucocorticoid intake in newly diagnosed systemic lupus erythematosus","volume":"164","author":"Zhao","year":"2025","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2026.107429_bib0225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1744666X.2023.2268284","article-title":"Anifrolumab: First biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus","volume":"20","author":"Gensous","year":"2024","journal-title":"Expert Rev Clin Immunol"},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2026.107429_bib0230","doi-asserted-by":"crossref","first-page":"381","DOI":"10.31138\/mjr.260624.cto","article-title":"Clinical trials of interferon inhibitors in systemic lupus erythematosus and preliminary real-world efficacy of anifrolumab","volume":"35","author":"D\u00edaz-Planellas","year":"2024","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0235","first-page":"846","article-title":"Validity of retrospective disease activity assessment in systemic lupus erythematosus","volume":"23","author":"Arce-Salinas","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0240","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0245","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0250","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1093\/rheumatology\/keq026","article-title":"Numerical scoring for the BILAG-2004 index","volume":"49","author":"Yee","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2026.107429_bib0255","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2026.107429_bib0260","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/art.24698","article-title":"Novel evidence-based systemic lupus erythematosus responder index","volume":"61","author":"Furie","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2026.107429_bib0265","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/rheumatology\/kev387","article-title":"From BILAG to BILAG-based combined lupus assessment-30 years on","volume":"55","author":"Murphy","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2026.107429_bib0270","doi-asserted-by":"crossref","first-page":"4","DOI":"10.31138\/mjr.28.1.4","article-title":"Flares in systemic lupus erythematosus: Diagnosis, risk factors and preventive strategies","volume":"28","author":"Adamichou","year":"2017","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0275","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1136\/annrheumdis-2015-207726","article-title":"Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)","volume":"75","author":"Franklyn","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2026.107429_bib0280","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000538","article-title":"2021 DORIS definition of remission in SLE: Final recommendations from an international task force","volume":"8","author":"van Vollenhoven","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.medcli.2026.107429_bib0285","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/acr2.11414","article-title":"Interferon inhibition for lupus with anifrolumab: Critical appraisal of the evidence leading to FDA approval","volume":"4","author":"Loncharich","year":"2022","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.medcli.2026.107429_bib0290","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.3899\/jrheum.2024-0053","article-title":"Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World","volume":"51","author":"Tani","year":"2024","journal-title":"Multicenter Study. J Rheumatol."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:40:34Z","timestamp":1780580434000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0025775326000795"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107429","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efectividad temprana de anifrolumab en lupus eritematoso sist\u00e9mico: datos de vida real a 3 y 6 meses del registro RALESA","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107429","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107429"}}